---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-005269"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:40:52.330561+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab invests RM 1M for equity stake in Ascension Innovation Sdn Bhd

## Summary
- Investment of RM 1 million (~USD 228k) for a significant equity stake in Ascension Innovation Sdn Bhd (AISB).
- AISB operates the aiCMS platform integrating predictive analytics and AI tools for healthcare.
- Investment executed through wholly-owned subsidiary MRNA Scientific Sdn Bhd on August 23, 2024.
- Collaboration aims to integrate BGLC's genomic screening services with AISB's digital health platforms.
- Strategic move to expand BGLC's presence in the digital health sector and enhance personalized care.

## SEC filing metadata
- accession: 0001477932-24-005269
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005269/0001477932-24-005269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005269/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-005269
- JSON: https://secwatch.observer/filing/0001477932-24-005269.json
- Plain text: https://secwatch.observer/filing/0001477932-24-005269.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.